Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress

Monoamine oxidase B (MAO-B) metabolizes dopamine and plays an important role in oxidative stress by altering the redox state of neuronal and glial cells. MAO-B inhibitors are a promising therapeutical approach for Parkinson’s disease (PD). Herein, 24 melatonin analogues (<b>3a</b>–<b&...

Full description

Bibliographic Details
Main Authors: Ahmed Elkamhawy, Jiyu Woo, Noha A. Gouda, Jushin Kim, Hossam Nada, Eun Joo Roh, Ki Duk Park, Jungsook Cho, Kyeong Lee
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/10/10/1604
_version_ 1827680291561406464
author Ahmed Elkamhawy
Jiyu Woo
Noha A. Gouda
Jushin Kim
Hossam Nada
Eun Joo Roh
Ki Duk Park
Jungsook Cho
Kyeong Lee
author_facet Ahmed Elkamhawy
Jiyu Woo
Noha A. Gouda
Jushin Kim
Hossam Nada
Eun Joo Roh
Ki Duk Park
Jungsook Cho
Kyeong Lee
author_sort Ahmed Elkamhawy
collection DOAJ
description Monoamine oxidase B (MAO-B) metabolizes dopamine and plays an important role in oxidative stress by altering the redox state of neuronal and glial cells. MAO-B inhibitors are a promising therapeutical approach for Parkinson’s disease (PD). Herein, 24 melatonin analogues (<b>3a</b>–<b>x</b>) were synthesized as novel MAO-B inhibitors with the potential to counteract oxidative stress in neuronal PC12 cells. Structure elucidation, characterization, and purity of the synthesized compounds were performed using <sup>1</sup>H-NMR, <sup>13</sup>C-NMR, HRMS, and HPLC. At 10 µM, 12 compounds showed >50% MAO-B inhibition. Among them, compounds <b>3n</b>, <b>3r</b>, and <b>3u</b>–<b>w</b> showed >70% inhibition of MAO-B and IC<sub>50</sub> values of 1.41, 0.91, 1.20, 0.66, and 2.41 µM, respectively. When compared with the modest selectivity index of rasagiline (<b>II</b>, a well-known MAO-B inhibitor, SI > 50), compounds <b>3n, 3r, 3u</b>, and <b>3v</b> demonstrated better selectivity indices (SI > 71, 109, 83, and 151, respectively). Furthermore, compounds <b>3n</b> and <b>3r</b> exhibited safe neurotoxicity profiles in PC12 cells and reversed 6-OHDA- and rotenone-induced neuronal oxidative stress. Both compounds significantly up-regulated the expression of the anti-oxidant enzyme, heme oxygenase (HO)-1. Treatment with Zn(II)-protoporphyrin IX (ZnPP), a selective HO-1 inhibitor, abolished the neuroprotective effects of the tested compounds, suggesting a critical role of HO-1 up-regulation. Both compounds increased the nuclear translocation of Nrf2, which is a key regulator of the antioxidative response. Taken together, these data show that compounds <b>3n</b> and <b>3r</b> could be further exploited for their multi-targeted role in oxidative stress-related PD therapy.
first_indexed 2024-03-10T06:45:39Z
format Article
id doaj.art-c630a0a8ffc644af9223996627ec7133
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T06:45:39Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-c630a0a8ffc644af9223996627ec71332023-11-22T17:16:36ZengMDPI AGAntioxidants2076-39212021-10-011010160410.3390/antiox10101604Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative StressAhmed Elkamhawy0Jiyu Woo1Noha A. Gouda2Jushin Kim3Hossam Nada4Eun Joo Roh5Ki Duk Park6Jungsook Cho7Kyeong Lee8College of Pharmacy, Dongguk University-Seoul, Goyang 10326, KoreaCollege of Pharmacy, Dongguk University-Seoul, Goyang 10326, KoreaCollege of Pharmacy, Dongguk University-Seoul, Goyang 10326, KoreaConvergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology (KIST), Seoul 02792, KoreaCollege of Pharmacy, Dongguk University-Seoul, Goyang 10326, KoreaChemical Kinomics Research Center, Korea Institute of Science and Technology (KIST), Seoul 02792, KoreaConvergence Research Center for Diagnosis, Treatment and Care System of Dementia, Korea Institute of Science and Technology (KIST), Seoul 02792, KoreaCollege of Pharmacy, Dongguk University-Seoul, Goyang 10326, KoreaCollege of Pharmacy, Dongguk University-Seoul, Goyang 10326, KoreaMonoamine oxidase B (MAO-B) metabolizes dopamine and plays an important role in oxidative stress by altering the redox state of neuronal and glial cells. MAO-B inhibitors are a promising therapeutical approach for Parkinson’s disease (PD). Herein, 24 melatonin analogues (<b>3a</b>–<b>x</b>) were synthesized as novel MAO-B inhibitors with the potential to counteract oxidative stress in neuronal PC12 cells. Structure elucidation, characterization, and purity of the synthesized compounds were performed using <sup>1</sup>H-NMR, <sup>13</sup>C-NMR, HRMS, and HPLC. At 10 µM, 12 compounds showed >50% MAO-B inhibition. Among them, compounds <b>3n</b>, <b>3r</b>, and <b>3u</b>–<b>w</b> showed >70% inhibition of MAO-B and IC<sub>50</sub> values of 1.41, 0.91, 1.20, 0.66, and 2.41 µM, respectively. When compared with the modest selectivity index of rasagiline (<b>II</b>, a well-known MAO-B inhibitor, SI > 50), compounds <b>3n, 3r, 3u</b>, and <b>3v</b> demonstrated better selectivity indices (SI > 71, 109, 83, and 151, respectively). Furthermore, compounds <b>3n</b> and <b>3r</b> exhibited safe neurotoxicity profiles in PC12 cells and reversed 6-OHDA- and rotenone-induced neuronal oxidative stress. Both compounds significantly up-regulated the expression of the anti-oxidant enzyme, heme oxygenase (HO)-1. Treatment with Zn(II)-protoporphyrin IX (ZnPP), a selective HO-1 inhibitor, abolished the neuroprotective effects of the tested compounds, suggesting a critical role of HO-1 up-regulation. Both compounds increased the nuclear translocation of Nrf2, which is a key regulator of the antioxidative response. Taken together, these data show that compounds <b>3n</b> and <b>3r</b> could be further exploited for their multi-targeted role in oxidative stress-related PD therapy.https://www.mdpi.com/2076-3921/10/10/1604bioactive moleculesoxidative stressneurodegenerationbrain healthParkinson’s diseaseMAO-B
spellingShingle Ahmed Elkamhawy
Jiyu Woo
Noha A. Gouda
Jushin Kim
Hossam Nada
Eun Joo Roh
Ki Duk Park
Jungsook Cho
Kyeong Lee
Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
Antioxidants
bioactive molecules
oxidative stress
neurodegeneration
brain health
Parkinson’s disease
MAO-B
title Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
title_full Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
title_fullStr Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
title_full_unstemmed Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
title_short Melatonin Analogues Potently Inhibit MAO-B and Protect PC12 Cells against Oxidative Stress
title_sort melatonin analogues potently inhibit mao b and protect pc12 cells against oxidative stress
topic bioactive molecules
oxidative stress
neurodegeneration
brain health
Parkinson’s disease
MAO-B
url https://www.mdpi.com/2076-3921/10/10/1604
work_keys_str_mv AT ahmedelkamhawy melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT jiyuwoo melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT nohaagouda melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT jushinkim melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT hossamnada melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT eunjooroh melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT kidukpark melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT jungsookcho melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress
AT kyeonglee melatoninanaloguespotentlyinhibitmaobandprotectpc12cellsagainstoxidativestress